Clinical - evolutionary and treatment aspects of patients with COVID-19 admitted in the intensive therapy unit
DOI:
https://doi.org/10.52692/1857-0011.2024.2-79.13Keywords:
COVID-19 , SARS-CoV-2 , Brixia score, D-dimers, ARDSAbstract
Aim. Emphasising the particularities of clinical, laboratory parameters, and the treatment results of critical patients with COVID-19 in the Intensive Care Unit. Material and methods. Totally 100 patients with COVID-19 admitted to the Intensive Care Unit of the Institute of Emergency Medicine Results. The most common comorbidities were hypertension, diabetes mellitus and obesity. The frequency of application of Oxygen therapy was 74.0% of patients; of non - invasive ventilation was 73.0% while frequency of invasive mechanical ventilation was 30.0% of patients. Conclusions. The treatment protocols led to a significant reduction in CRP, hemoglobin and albumin levels and statistically increase of D-dimer, leukocyte, platelet, ESR, and ALT levels.
References
Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020; 323(16): 1545-1546.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS- CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16): 1574-1581.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-1720.
Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020; 39(5): 405-407.
Ghahramani S, Tabrizi R, Lankarani K, Kashani S, Rezaei S, Zeidi N et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020; 25(1): 30.
Keddie S, Ziff O, Chou M, Taylor R, Heslegrave A, Garr E et al. Laboratory biomarkers associated with COVID-19 severity and management. Clin Immunol. 2020; 221: 108614.
Infecția cu coronavirus de tip nou (COVID-19). Protocol clinic național provizoriu (ediția III). PCN-371. Chișinău, 2020. 65 p.
Infecția cu coronavirus de tip nou (COVID-19).Protocol clinic național provizoriu (ediția IV). PCN-371. Chișinău, 2020. 78 p.
Managementul complicațiilor severe cauzate de infecția provocată de coronavirus (COVID-19). Ghid practic. Chișinău, 2020. 67 p.
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236): 1569- 1578.
Fogante M, Cavagna E, Rinaldi G. Chest X-Ray Scoring System in COVID-19 Pneumonia: An Added Value in the Evaluation of the Disease Severity. EJMO. 2021; 5(4): 305-310.
Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8): 782-793.
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
